Treatment Considerations for CLL

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Treatment Considerations for CLL

Treatment Considerations for CLL

Playback speed

10 seconds

Treatment Considerations for Patients With CLL Who Are Elderly or Have Comorbid Medical Conditions

By Northwell Health FEATURING Joanna Rhodes

170 views

December 8, 2022

0 Comments

Treatment Considerations for CLL

08:57

Carsten Utoft Niemann

Fixed-Duration Therapy in CLL: Is It a Safer Option for Patients?

09:46

Christopher Pleyer

Venetoclax + Obinutuzumab for Previously Untreated CLL: Latest Learn…

19:42

Jacqueline Barrientos

Considerations for Sequencing Treatments in CLL

14:05

The University of Kansas Cancer Center

Five-Year Updates on Venetoclax + Obinutuzumab for Previously Untrea…

Feat. M. Hoffmann

33:21

Moffitt Cancer Center

MRD in CLL/SLL: Is It Ready for Prime Time?

Feat. J. Sandoval-Sus

27:08

Tara Graff

Updates on Venetoclax in CLL

09:45

ASH 2022 Conference Coverage

ASH 2022 Treatment of CLL-Associated Autoimmune Cytopenias and Outco…

Feat. K. Rogers

11:52

ASH 2022 Conference Coverage

ASH 2022 Real-World OS and TTNT by 1L Therapy (BTKi and BCL2i) in Pa…

Feat. W. Archibald, C. Wang

07:24

Kirollos Hanna

MURANO Phase 3 Trial: Enduring Undetectable MRD and Updated Outcomes…

14:12

Northwell Health

Treatment Considerations for Patients With CLL Who Are Elderly or Ha…

Feat. J. Rhodes

14:31

Lydia Scarfò

Upcoming BTKi Therapies in CLL

11:07

SOHO 2022 Tenth Annual Meeting

SOHO 2022: BCL2i in CLL

Feat. A. Chanan-Khan

20:55

ERIC 2022 - European Research Initiative on CLL - ERIC

The Tumor: Biomarker-Guided Treatment in CLL

Feat. O. Al-Sawaf

21:28

ERIC 2022 - European Research Initiative on CLL - ERIC

Combined Inhibition of Signaling and Anti-Apoptotic Pathways in CLL

Feat. P. Hillmen

06:33

Arnon Kater